Drug information for VIDEX
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
FOR SOLUTION; ORAL
100MG/PACKET
Discontinued
DIDANOSINE
Didanosine
BRISTOL MYERS SQUIBB
20155
2010-08-09 Other Important Information from FDA
2007-11-19 Review
2007-08-06 Review
2007-08-06 Review
2006-12-28 Letter
2006-12-04 Label
2006-09-18 Letter
2006-08-21 Label
2005-04-27 Review
2005-04-27 Review
2005-04-19 Review
2005-04-19 Review
2005-01-06 Review
2004-08-09 Review
2004-06-30 Letter
2004-06-30 Label
2004-01-22 Label
2004-01-22 Letter
2003-04-21 Label
2003-04-21 Label
2003-03-10 Letter
2003-03-07 Label
2002-09-25 Letter
2002-09-25 Label
2002-04-01 Label
2002-04-01 Letter
1999-10-29 Letter
1999-10-29 Label
FOR SOLUTION; ORAL
167MG/PACKET
Discontinued
DIDANOSINE
Didanosine
BRISTOL MYERS SQUIBB
"
FOR SOLUTION; ORAL
250MG/PACKET
Discontinued
DIDANOSINE
Didanosine
BRISTOL MYERS SQUIBB
"
FOR SOLUTION; ORAL
375MG/PACKET
Discontinued
DIDANOSINE
Didanosine
BRISTOL MYERS SQUIBB
"
FOR SOLUTION; ORAL
10MG/ML
Prescription
AA (Reference Drug)
DIDANOSINE
Didanosine
BRISTOL MYERS SQUIBB
20156
2011-11-22 Label
2011-11-22 Letter
2011-11-22 Medication Guide
2011-05-12 Letter
2010-08-09 Other Important Information from FDA
2010-07-20 Other
2010-02-01 Letter
2010-01-29 Medication Guide
2010-01-29 Label
2009-06-22 Label
2009-06-17 Letter
2007-11-19 Review
2007-08-06 Review
2007-08-06 Review
2006-12-28 Letter
2006-12-04 Label
2006-09-18 Letter
2006-08-21 Label
2005-04-27 Review
2005-04-27 Review
2005-04-19 Review
2005-04-19 Review
2005-01-06 Review
2004-08-09 Review
2004-01-22 Label
2004-01-22 Letter
2003-04-21 Label
2003-04-21 Label
2003-03-10 Letter
2003-03-07 Label
2002-09-25 Label
2002-09-25 Letter
2002-09-25 Label
2002-09-25 Letter
2002-04-01 Label
2002-04-01 Letter
1999-10-29 Letter
1999-10-21 Label
TABLET, CHEWABLE; ORAL
100MG
Discontinued
DIDANOSINE
Didanosine
BRISTOL MYERS SQUIBB
20154
2010-08-09 Other Important Information from FDA
2007-11-19 Review
2007-08-06 Review
2007-08-06 Review
2007-08-06 Review
2006-12-28 Letter
2006-12-04 Label
2006-09-18 Letter
2006-08-21 Label
2005-04-27 Review
2005-04-27 Review
2005-04-19 Review
2005-04-19 Review
2005-01-06 Review
2004-08-09 Review
2004-08-09 Review
2004-01-22 Letter
2004-01-22 Label
2003-04-21 Label
2003-04-21 Label
2003-03-10 Letter
2003-03-06 Label
2002-09-25 Label
2002-09-25 Letter
2002-09-25 Label
2002-09-25 Letter
2002-04-01 Label
2002-04-01 Letter
1999-10-29 Letter
1999-10-29 Label
1999-10-29 Letter
1999-10-29 Label
TABLET, CHEWABLE; ORAL
150MG
Discontinued
DIDANOSINE
Didanosine
BRISTOL MYERS SQUIBB
"
TABLET, CHEWABLE; ORAL
200MG
Discontinued
DIDANOSINE
Didanosine
BRISTOL MYERS SQUIBB
"
TABLET, CHEWABLE; ORAL
25MG
Discontinued
DIDANOSINE
Didanosine
BRISTOL MYERS SQUIBB
"
TABLET, CHEWABLE; ORAL
50MG
Discontinued
DIDANOSINE
Didanosine
BRISTOL MYERS SQUIBB
"
Drug Adverse Effects information for VIDEX
Role code
Indications
Reaction
# Reports
PS
HAEMARTHROSIS
ALANINE AMINOTRANSFERASE INCREASED
1
PS
HAEMARTHROSIS
ASPARTATE AMINOTRANSFERASE INCREASED
1
PS
HAEMARTHROSIS
DIZZINESS
1
PS
HAEMARTHROSIS
PALPITATIONS
1
PS
HAEMARTHROSIS
PULMONARY HYPERTENSION
1
PS
HIV INFECTION
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS
5
PS
HIV INFECTION
ALANINE AMINOTRANSFERASE INCREASED
8
PS
HIV INFECTION
ASPARTATE AMINOTRANSFERASE INCREASED
8
PS
HIV INFECTION
ASTHENIA
5
PS
HIV INFECTION
CASTLEMAN'S DISEASE
5
PS
HIV INFECTION
DIZZINESS
8
PS
HIV INFECTION
DRUG RESISTANCE
5
PS
HIV INFECTION
PALPITATIONS
8
PS
HIV INFECTION
PANCYTOPENIA
5
PS
HIV INFECTION
PORTAL HYPERTENSION
9
PS
HIV INFECTION
PORTAL VEIN THROMBOSIS
1
PS
HIV INFECTION
PREGNANCY
8
PS
HIV INFECTION
PULMONARY HYPERTENSION
8
PS
HIV INFECTION
SPLENIC VEIN THROMBOSIS
1
PS
HIV INFECTION
VARICES OESOPHAGEAL
1
PS
HIV INFECTION
WEIGHT DECREASED
5
SS
ANTIRETROVIRAL THERAPY
DRUG RESISTANCE
15
SS
ANTIRETROVIRAL THERAPY
PSYCHIATRIC SYMPTOM
15
SS
ANTIVIRAL TREATMENT
ABORTION SPONTANEOUS
5
SS
ANTIVIRAL TREATMENT
MATERNAL EXPOSURE DURING PREGNANCY
5
SS
HIV INFECTION
ABORTION INDUCED
3
SS
HIV INFECTION
ABORTION SPONTANEOUS
3
SS
HIV INFECTION
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS
10
SS
HIV INFECTION
AGGRESSION
4
SS
HIV INFECTION
ANAPHYLACTIC SHOCK
10
SS
HIV INFECTION
APPARENT LIFE THREATENING EVENT
20
SS
HIV INFECTION
ASCITES
4
SS
HIV INFECTION
ASTHENIA
10
SS
HIV INFECTION
CASTLEMAN'S DISEASE
10
SS
HIV INFECTION
DIZZINESS
20
SS
HIV INFECTION
DRUG INTERACTION
3
SS
HIV INFECTION
DRUG RESISTANCE
10
SS
HIV INFECTION
ENDOLYMPHATIC HYDROPS
10
SS
HIV INFECTION
GENERALISED ERYTHEMA
10
SS
HIV INFECTION
GYNAECOMASTIA
10
SS
HIV INFECTION
HEPATIC NECROSIS
4
SS
HIV INFECTION
HEPATITIS A
4
SS
HIV INFECTION
INSOMNIA
3
SS
HIV INFECTION
JAUNDICE
4
SS
HIV INFECTION
MENIERE'S DISEASE
10
SS
HIV INFECTION
PALPITATIONS
20
SS
HIV INFECTION
PANCREATITIS
10
SS
HIV INFECTION
PANCREATITIS ACUTE
6
SS
HIV INFECTION
PANCYTOPENIA
10
SS
HIV INFECTION
PERITONEAL HAEMATOMA
4
SS
HIV INFECTION
PREGNANCY
6
SS
HIV INFECTION
PULMONARY HYPERTENSION
20
SS
HIV INFECTION
SOMNOLENCE
4
SS
HIV INFECTION
VERTIGO
3
SS
HIV INFECTION
VOMITING
4
SS
HIV INFECTION
WEIGHT DECREASED
10
SS
HYPERPHOSPHATAEMIA
DRUG INTERACTION
1
SS
HYPERPHOSPHATAEMIA
PANCREATITIS ACUTE
3
SS
HYPERTENSION
DRUG INTERACTION
2
SS
HYPERTENSION
PANCREATITIS ACUTE
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
ABORTION SPONTANEOUS
5
SS
RENAL FAILURE
DRUG INTERACTION
1
SS
RENAL FAILURE
PANCREATITIS ACUTE
1
C
ASYMPTOMATIC HIV INFECTION
CONVULSION
3
C
ASYMPTOMATIC HIV INFECTION
LOSS OF CONSCIOUSNESS
3
C
ASYMPTOMATIC HIV INFECTION
MASKED FACIES
3
C
ASYMPTOMATIC HIV INFECTION
MUSCULOSKELETAL STIFFNESS
3
C
HIV INFECTION
ABDOMINAL PAIN UPPER
8
C
HIV INFECTION
ASTHENIA
16
C
HIV INFECTION
DEPRESSION
2
C
HIV INFECTION
DIZZINESS
8
C
HIV INFECTION
DRY SKIN
4
C
HIV INFECTION
ECZEMA
2
C
HIV INFECTION
FACE OEDEMA
8
C
HIV INFECTION
HEADACHE
8
C
HIV INFECTION
HIDRADENITIS
1
C
HIV INFECTION
HYPERSENSITIVITY
16
C
HIV INFECTION
LIP OEDEMA
8
C
HIV INFECTION
LIPODYSTROPHY ACQUIRED
2
C
HIV INFECTION
LIPOHYPERTROPHY
2
C
HIV INFECTION
NAUSEA
8
C
HIV INFECTION
OSTEONECROSIS
4
C
HIV INFECTION
PHARYNGOTONSILLITIS
2
C
HIV INFECTION
PREGNANCY
4
C
HIV INFECTION
PYREXIA
16
C
HIV INFECTION
RASH
8
C
HIV INFECTION
SINUSITIS
2
C
HIV INFECTION
SUICIDE ATTEMPT
2
C
HIV INFECTION
THROAT IRRITATION
4
C
HIV INFECTION
VOMITING
12
C
PRODUCT USED FOR UNKNOWN INDICATION
CONVULSION
6
C
PRODUCT USED FOR UNKNOWN INDICATION
LOSS OF CONSCIOUSNESS
6
C
PRODUCT USED FOR UNKNOWN INDICATION
MASKED FACIES
6
C
PRODUCT USED FOR UNKNOWN INDICATION
MUSCULOSKELETAL STIFFNESS
6
C
URINARY TRACT INFECTION
CONVULSION
1
C
URINARY TRACT INFECTION
LOSS OF CONSCIOUSNESS
1
C
URINARY TRACT INFECTION
MASKED FACIES
1
C
URINARY TRACT INFECTION
MUSCULOSKELETAL STIFFNESS
1
I
HIV INFECTION
DRUG INTERACTION
12
I
HIV INFECTION
PANCREATITIS ACUTE
12
I
HYPERPHOSPHATAEMIA
DRUG INTERACTION
6
I
HYPERPHOSPHATAEMIA
PANCREATITIS ACUTE
6
I
HYPERTENSION
DRUG INTERACTION
8
I
HYPERTENSION
PANCREATITIS ACUTE
8
I
RENAL FAILURE
DRUG INTERACTION
2
I
RENAL FAILURE
PANCREATITIS ACUTE
2
Ads by Google